Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

Michael J Valenzuela, David Bartres-Faz, Mirza Faisal Beg, A Fornito, Emilio V Merlo-Pich, Ulrich Muller, Dost Ongur, Arthur W Toga, M Yucel

Research output: Contribution to journalLetterOtherpeer-review

7 Citations (Scopus)


Neuroimaging can now reveal an extraordinary amount of information about the structural, functional and biochemical characteristics of the human brain. Further understanding the biological processes underlying brain dysfunction, and how these adapt to treatment, is clearly of significance to researchers involved in medical trials.
Original languageEnglish
Pages (from-to)1064-1066
Number of pages3
JournalMolecular Psychiatry
Issue number11
Publication statusPublished - 31 May 2011
Externally publishedYes

Cite this